Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MRC Technology patents novel protein kinase inhibitors

Sep. 28, 2010

CHMP recommends approval of Tasigna in E.U. as first-line therapy for Ph+ CML

Sep. 28, 2010

PLX-4032 shows promise to treat BRAF mutation-positive melanoma

Sep. 28, 2010

NexMed and Bio-Quant present preclinical data on PrevOnco

Sep. 28, 2010

FDA orphan drug status for darinaparsin in peripheral T-cell lymphoma

Sep. 27, 2010

S*BIO obtains funding to support clinical programs

Sep. 27, 2010

FDA and EMA to review vandetanib for advanced medullary thyroid cancer

Sep. 27, 2010

Pro-Pharmaceuticals and Numoda collaborate on phase III Davanat trial

Sep. 27, 2010

University of Kansas claims new HSP 90 inhibitors

Sep. 27, 2010

Novartis reports on clinical development of LDE-225

Sep. 27, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...